Lessee, Operating Lease, Liability, to be Paid, Year Two of Indaptus Therapeutics, Inc. from 31 Dec 2021 to 31 Dec 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Indaptus Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD history and change rate from 31 Dec 2021 to 31 Dec 2023.
  • Indaptus Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Dec 2023 was $86,862.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)

Indaptus Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 $86,862 31 Dec 2023 10-K 13 Mar 2024 2023 FY
Q3 2023 $86,862 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $86,862 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $101,705 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2021 $82,387 31 Dec 2021 10-K 21 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.